Barclays Increases BKV (NYSE:BKV) Price Target to $29.00

BKV (NYSE:BKV - Free Report) had its price objective raised by Barclays from $28.00 to $29.00 in a research note released on Monday morning,Benzinga reports. They currently have an overweight rating on the stock.

Several other analysts have also commented on BKV. KeyCorp decreased their price target on shares of BKV from $27.00 to $25.00 and set an "overweight" rating for the company in a research report on Tuesday, March 4th. Truist Financial cut their price target on shares of BKV from $31.00 to $30.00 and set a "buy" rating on the stock in a report on Monday, March 17th. Eight equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, BKV has a consensus rating of "Buy" and a consensus target price of $27.88.

BKV Price Performance

NYSE:BKV traded down $0.26 during trading hours on Monday, hitting $22.30. 293,101 shares of the stock traded hands, compared to its average volume of 460,668. BKV has a 1 year low of $15.00 and a 1 year high of $26.78. The stock has a 50 day moving average price of $19.15 and a 200 day moving average price of $21.25.

BKV (NYSE:BKV - Get Free Report) last announced its quarterly earnings results on Friday, May 9th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.15 by $0.26. The business had revenue of $216.13 million during the quarter, compared to the consensus estimate of $223.20 million. Research analysts expect that BKV will post -1.82 EPS for the current fiscal year.

Insider Activity at BKV

In other news, insider Lindsay B. Larrick sold 15,000 shares of the business's stock in a transaction dated Tuesday, March 25th. The stock was sold at an average price of $21.07, for a total transaction of $316,050.00. Following the completion of the transaction, the insider now directly owns 245,528 shares of the company's stock, valued at approximately $5,173,274.96. The trade was a 5.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO David Tameron sold 4,409 shares of the business's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $17.94, for a total value of $79,097.46. Following the transaction, the chief financial officer now directly owns 43,370 shares of the company's stock, valued at approximately $778,057.80. This represents a 9.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 118,675 shares of company stock worth $2,389,090.

Institutional Investors Weigh In On BKV

Several institutional investors have recently added to or reduced their stakes in the business. Quantbot Technologies LP purchased a new stake in BKV during the first quarter worth approximately $1,605,000. Bank of New York Mellon Corp lifted its stake in BKV by 21.2% in the first quarter. Bank of New York Mellon Corp now owns 35,453 shares of the company's stock valued at $745,000 after buying an additional 6,209 shares during the last quarter. California State Teachers Retirement System purchased a new stake in BKV in the fourth quarter valued at approximately $26,000. Driehaus Capital Management LLC purchased a new stake in BKV in the fourth quarter valued at approximately $9,553,000. Finally, Geode Capital Management LLC purchased a new stake in BKV in the fourth quarter valued at approximately $7,728,000.

BKV Company Profile

BKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas.